Age-related Cognitive Decline Assay
Measuring decline in neuronal function with age

C. elegans, with its well-mapped nervous system and neurotransmitter similarities to humans, presents a unique model for studying age-related cognitive decline. The decline in dopaminergic responses associated with ageing mirrors conditions like Parkinson’s disease (PD) in humans.
The Challenge:
Current behavioural assays using rodents for studying cognitive decline are expensive, time-consuming, and lack translatability to human conditions, hindering progress in anti-ageing therapeutic development.
Our Solution:
Magnitude Biosciences leverages C. elegans and our proprietary WormGazer™ technology to provide our novel Age-related Cognitive (ARC) Functional Decline Assay. This assay quantifies cognitive decline in aged worms and neurodegenerative disease models, offering a cost-effective and efficient alternative to rodent models.
The ARC Assay:
Our ARC assay measures cognitive function through a chemotaxis-dependent behavior that declines with age. By automating data acquisition with our WormGazer™ technology, we can evaluate the effects of compounds and disease models on cognitive health in C. elegans. Worms of various ages are placed a fixed distance from their food source. As they age, it takes longer for them to find their food, and they are less able to cognitively localise themselves to the food.


Worms of various ages are placed a fixed distance from their food source. As they age, it takes longer for them to find their food, and they are less able to cognitively localise themselves to the food.
Key Benefits:
Partner with us for Neuronal Function Research
Collaborate with Magnitude Biosciences to accelerate your research on age-related cognitive decline. Our ARC assay provides a streamlined approach to assess compound efficacy.
Get in touch today to find out how we can support you to accelerate your research
© 2025 Magnitude Biosciences Ltd.
Registered in England and Wales under Company Number 11579884. All rights reserved.

